BR112013013134A2 - método de preparação de metaxalona, metaxalona, e, composição farmacêutica - Google Patents
método de preparação de metaxalona, metaxalona, e, composição farmacêuticaInfo
- Publication number
- BR112013013134A2 BR112013013134A2 BR112013013134A BR112013013134A BR112013013134A2 BR 112013013134 A2 BR112013013134 A2 BR 112013013134A2 BR 112013013134 A BR112013013134 A BR 112013013134A BR 112013013134 A BR112013013134 A BR 112013013134A BR 112013013134 A2 BR112013013134 A2 BR 112013013134A2
- Authority
- BR
- Brazil
- Prior art keywords
- metaxalone
- solvent
- tgic
- pharmaceutical composition
- preparation
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
- C07D263/08—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D263/16—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D263/18—Oxygen atoms
- C07D263/20—Oxygen atoms attached in position 2
- C07D263/24—Oxygen atoms attached in position 2 with hydrocarbon radicals, substituted by oxygen atoms, attached to other ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
- A61K31/421—1,3-Oxazoles, e.g. pemoline, trimethadione
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/02—Local antiseptics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
Abstract
método de preparação de metaxalona, metaxalona, e, composição farmacêutica. a presente invenção se refere a um método de preparação de metaxalona compreendendo reação de isocianurato de triglicidila (tgic) com m-xilenol, em que a dita reação é realizada em uma mistura de solvente compreendendo um solvente polar aprótico com constante dielétrica maior ou igual a 30 e pelo menos um outro solvente selecionado do grupo compreendendo solvente apolares e solventes polares apróticos com constante dielétrica abaixo de 30 a dita mistura de solvente compreendendo de 5 a 40% em peso do dito primeiro solvente e de 95 a 60% em peso do dito segundo solvente, adicionando a tgic a uma temperatura entre 30°c e 50°c, e depois adicionando a tgic, aumentando a temperatura da solução da reação para um valor entre 80°c em um tempo entre 120 e 180 minutos a uma taxa de aumento não maior que 1,25°c por minuto. a invenção também se refere a um metaxalona com um baixo teor de impureza derivadas de reações incompletas e/ou reações laterais do método de produção.
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP11152849.3 | 2011-02-01 | ||
| EP11152849 | 2011-02-01 | ||
| US201161439127P | 2011-02-03 | 2011-02-03 | |
| US61/439,127 | 2011-02-03 | ||
| PCT/EP2012/050609 WO2012104139A1 (en) | 2011-02-01 | 2012-01-17 | Method of preparation of metaxalone |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| BR112013013134A2 true BR112013013134A2 (pt) | 2016-08-23 |
| BR112013013134B1 BR112013013134B1 (pt) | 2021-06-08 |
Family
ID=44115617
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR112013013134-9A BR112013013134B1 (pt) | 2011-02-01 | 2012-01-17 | método de preparação de metaxalona |
Country Status (27)
| Country | Link |
|---|---|
| US (2) | US20130261160A1 (pt) |
| EP (1) | EP2670737B1 (pt) |
| JP (1) | JP2014503564A (pt) |
| KR (1) | KR101907599B1 (pt) |
| CN (1) | CN103298797B (pt) |
| AR (1) | AR084946A1 (pt) |
| AU (1) | AU2012213666B2 (pt) |
| BR (1) | BR112013013134B1 (pt) |
| CA (1) | CA2817462C (pt) |
| CY (1) | CY1118348T1 (pt) |
| DK (1) | DK2670737T3 (pt) |
| EA (1) | EA024417B1 (pt) |
| ES (1) | ES2605425T3 (pt) |
| GE (1) | GEP20156352B (pt) |
| HK (1) | HK1191006A1 (pt) |
| HR (1) | HRP20161660T1 (pt) |
| HU (1) | HUE029476T2 (pt) |
| IL (1) | IL226329A (pt) |
| LT (1) | LT2670737T (pt) |
| MX (1) | MX339346B (pt) |
| PL (1) | PL2670737T3 (pt) |
| PT (1) | PT2670737T (pt) |
| SG (2) | SG192090A1 (pt) |
| SI (1) | SI2670737T1 (pt) |
| SM (1) | SMT201600415B (pt) |
| UA (1) | UA114593C2 (pt) |
| WO (1) | WO2012104139A1 (pt) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR102181881B1 (ko) | 2014-11-21 | 2020-11-24 | 삼성디스플레이 주식회사 | 비전 검사 장치 및 이의 감마 및 얼룩 보정 방법 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE1545951A1 (de) * | 1965-07-24 | 1970-05-14 | Henkel & Cie Gmbh | Verfahren zur Herstellung von substituierten Oxazolidonen |
| FR1487641A (fr) | 1965-07-24 | 1967-07-07 | Henkel & Cie Gmbh | Procédé de préparation d'oxazolidones substituées |
| WO2003061552A2 (en) * | 2002-01-14 | 2003-07-31 | Sun Pharmaceutical Industries Limited | Novel process for the preparation of substantially pure 5-(3,5-dimethylphenoxy)methyl-2-oxazolidinone |
| US6562980B1 (en) * | 2002-08-19 | 2003-05-13 | Yung Shin Pharma Ind. Co., Ltd. | Method for producing 5-aryloxymethyl-2-oxazolidinones |
| WO2007074477A2 (en) * | 2005-12-29 | 2007-07-05 | Dabur Pharma Limited | Metaxalone polymorphs |
| WO2008006096A1 (en) | 2006-07-07 | 2008-01-10 | Boehringer Ingelheim Chemicals, Inc. | Metaxalone synthesis |
| CN101921241A (zh) * | 2009-06-12 | 2010-12-22 | 北京京卫燕康药物研究所有限公司 | 具有光学活性的美他沙酮的合成 |
-
2012
- 2012-01-17 EA EA201390787A patent/EA024417B1/ru unknown
- 2012-01-17 SG SG2013055991A patent/SG192090A1/en unknown
- 2012-01-17 PL PL12700288T patent/PL2670737T3/pl unknown
- 2012-01-17 HU HUE12700288A patent/HUE029476T2/en unknown
- 2012-01-17 ES ES12700288.9T patent/ES2605425T3/es active Active
- 2012-01-17 GE GEAP201213202A patent/GEP20156352B/en unknown
- 2012-01-17 DK DK12700288.9T patent/DK2670737T3/en active
- 2012-01-17 SG SG10201600357WA patent/SG10201600357WA/en unknown
- 2012-01-17 UA UAA201305952A patent/UA114593C2/uk unknown
- 2012-01-17 EP EP12700288.9A patent/EP2670737B1/en active Active
- 2012-01-17 AU AU2012213666A patent/AU2012213666B2/en active Active
- 2012-01-17 US US13/990,974 patent/US20130261160A1/en not_active Abandoned
- 2012-01-17 BR BR112013013134-9A patent/BR112013013134B1/pt active IP Right Grant
- 2012-01-17 WO PCT/EP2012/050609 patent/WO2012104139A1/en active Application Filing
- 2012-01-17 PT PT127002889T patent/PT2670737T/pt unknown
- 2012-01-17 SI SI201230789A patent/SI2670737T1/sl unknown
- 2012-01-17 CN CN201280004303.XA patent/CN103298797B/zh active Active
- 2012-01-17 LT LTEP12700288.9T patent/LT2670737T/lt unknown
- 2012-01-17 KR KR1020137016255A patent/KR101907599B1/ko active IP Right Grant
- 2012-01-17 CA CA2817462A patent/CA2817462C/en active Active
- 2012-01-17 MX MX2013008426A patent/MX339346B/es active IP Right Grant
- 2012-01-17 JP JP2013550823A patent/JP2014503564A/ja active Pending
- 2012-01-30 AR ARP120100285A patent/AR084946A1/es active IP Right Grant
-
2013
- 2013-05-13 IL IL226329A patent/IL226329A/en active IP Right Grant
-
2014
- 2014-04-30 HK HK14104176.2A patent/HK1191006A1/zh unknown
-
2015
- 2015-06-17 US US14/742,203 patent/US9416116B2/en active Active
-
2016
- 2016-11-15 SM SM201600415T patent/SMT201600415B/it unknown
- 2016-12-01 CY CY20161101242T patent/CY1118348T1/el unknown
- 2016-12-06 HR HRP20161660TT patent/HRP20161660T1/hr unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2014366334B2 (en) | Mono- and dialkyl ethers of furan-2,5-dimethanol and (tetra-hydrofuran-2,5-diyl)dimethanol and amphiphilic derivatives thereof | |
| PH12014502141A1 (en) | New indanyloxydihydrobenzofuranylacetic acid derivatives and their use as gpr40 receptor agonists | |
| BR112014014881A2 (pt) | método para isolar ácido carboxílico a partir de solução aquosa | |
| SI2970332T1 (en) | Chemical entities | |
| BR112013011593A2 (pt) | cristal de derivado de morfinan 7-carbamoíla-6,7-insaturada e método para produzir o mesmo | |
| BR112014005452A2 (pt) | método para fabricação de copolímero de bloco | |
| BR112013026321A2 (pt) | composto, tensoativo, produto formulado, e, processo para a preparação de betaína | |
| ECSP13013012A (es) | Análogos del ácido epoxieicosatrienoicos y métodos de preparación | |
| MX2015011566A (es) | Sal novedosa de abexinostato, forma cristalina asociada, método de preparacion de la misma y las composiciones farmaceuticas que contienen la misma. | |
| BR112014026772A2 (pt) | composição de confeitaria, método para a mesma e artigos de confeitaria associados | |
| BR112013022975A2 (pt) | composições contendo copolímeros | |
| BR112013030391A2 (pt) | derivados de piperidina 3- espirocíclicos como agonistas dos receptores de grelina | |
| MX2010009607A (es) | Derivados de piridina triciclicos, medicamentos que contienen tales compuestos, su uso y proceso para su preparacion. | |
| BR112021018733A2 (pt) | Composições de d-metirosina e métodos para preparar as mesmas | |
| RU2012134349A (ru) | 2,5,7-замещенные производные оксазолпиримидина | |
| NZ711191A (en) | Benzo-fused heterocyclic derivatives useful as agonists of gpr120 | |
| BR112017013025A2 (pt) | recuperação de óleo da lama de palma | |
| BR112013013134A2 (pt) | método de preparação de metaxalona, metaxalona, e, composição farmacêutica | |
| BR112018007709A2 (pt) | processo de produção de 5-hidroximetilfurfural na presença de um catalisador tipo ácido de lewis e/ou de um catalisador tipo base heterogêneo e de um catalisador orgânico homogêneo tipo ácido de brønsted na presença de pelo menos um solvente polar aprótico | |
| NZ700221A (en) | Ralfinamide methanesulfonate salts | |
| RU2010150483A (ru) | Аддукты фуллерена и способ их получения | |
| BR112016007646A2 (pt) | forma cristalina anidra de cabazitaxel, uso da forma cristalina anidra de cabazitaxel, composição farmacêutica e processo para o preparo forma cristalina anidra de cabazitaxe | |
| IN2013MU03508A (pt) | ||
| JP2014133891A5 (pt) | ||
| CO6680709A2 (es) | Nuevos derivados dihidrobenzoxatiazepinas, su procedimiento de preparación y las composiciones farmacéuticas que los contienen |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
| B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
| B07E | Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] |
Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI |
|
| B06T | Formal requirements before examination [chapter 6.20 patent gazette] | ||
| B09A | Decision: intention to grant [chapter 9.1 patent gazette] | ||
| B16A | Patent or certificate of addition of invention granted [chapter 16.1 patent gazette] |
Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 17/01/2012, OBSERVADAS AS CONDICOES LEGAIS. |